Ho, C., Cimon, K. and Rabb, D. (2013) CADTH Rapid Response Reports. In: Transcatheter Aortic Valve Replacement in Severe Aortic Stenosis: A Review of Comparative Durability and Clinical Effectiveness beyond 12 Months, Canadian Agency for Drugs and Technologies in Health, Ottawa.

has been cited by the following article:

• TITLE: Insulin Requirements and Management in Trans-Catheter vs. Surgical Aortic Valve Replacement

  AUTHORS: Yunyan Qu, Liyu Xing, Nazanene H. Esfandiari, George M. Deeb, Roma Gianchandani

  KEYWORDS: Aortic Stenosis, Diabetes Mellitus, Trans-Catheter Aortic Valve Replacement, Surgical Aortic Valve Replacement, Blood Glucose Management

  JOURNAL NAME: Open Journal of Thoracic Surgery, Vol.9 No.3, September 18, 2019

  ABSTRACT: Objective: Trans-catheter Aortic Valve Replacement/Aortic Valve Implantation (TAVR) are increasingly performed today. We compared insulin requirements between TAVR and Surgical Aortic Valve Replacement (SAVR) patients with and without diabetes mellitus (DM) to determine optimal glucose management strategies during the perioperative period (POP). Methods: Charts of consecutive patients undergoing aortic procedures were retrospectively reviewed for glucose ranges, insulin requirements and routes of insulin administration (subcutaneous vs. intravenous) for patients with and without DM to maintain BG Results: Patients with SAVRs without DM and A1C Conclusions: TAVR patients have different insulin requirements compared to SAVRs (p